Bowhead Specialty Holdings Inc. BOW R2K
Company Overview
Bowhead Specialty Holdings Inc. provides commercial specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions, including directors and officers liability, errors and omissions liability, employment practices liability, fiduciary liability, fidelity liability and miscellaneous professional liability, crime insurance, and cyber for financial institutions; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and management liability segments. In addition, it offers Baleen Specialty, a technology-powered underwriting operation, that specializes in small to mid-sized risks that are not eligible in the admitted market. It distributes its products through distribution partners in wholesale and retail markets. The company was formerly known as Bowhead Holdings Inc. and changed its name to Bowhead Specialty Holdings Inc. in March 2024. The company was founded in 2020 and is based in New York, New York.
Why Investors Should Care
Net profit has compounded at 68.4% per year over the last five years.
Revenue has grown at a 43.3% CAGR over the past five years.
Trades at an undemanding P/E of 17.8.
Operating margin of 15.7% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.32.
Recent Developments
- Dec 2025 Revenue of $551.59M (+29.6% YoY); net profit $53.79M.
- Trailing 12 Months Year-on-year growth — revenue +26.9%, earnings +41.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 43.3%, profit CAGR 68.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 43.26% |
| 1 Year: | 26.90% |
Compounded Profit Growth
| 5 Years: | 68.43% |
| 1 Year: | 41.20% |
Stock Price Performance
| 1 Year: | -8.95% |
| 6 Months: | +23.61% |
| 3 Months: | +25.83% |
| 1 Month: | +12.35% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)59.98 · Neutral
P/E of 17.83 is above the sector median of 13.30 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 43.3% over 5 years.
- Profit CAGR of 68.4% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BOW Bowhead Specialty Holdings Inc. R2K | 30.84 | 17.83 | $1.01B | 0.00% | - | 13.73% | 43.26% | 68.43% |
| 2 | JPM JPMorgan Chase & Co. SPX | 342.89 | 16.42 | $918.78B | 1.87% | - | 16.47% | 5.35% | 7.56% |
| 3 | BRK-B Berkshire Hathaway Inc. SPX | 491.09 | 14.61 | $686.70B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPX | 356.02 | 31.01 | $590.89B | 0.83% | 37.15% | 60.35% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPX | 538.02 | 31.10 | $471.86B | 0.71% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPX | 60.62 | 15.04 | $430.20B | 2.00% | - | 10.64% | 6.00% | 3.49% |
| 7 | MS Morgan Stanley SPX | 227.67 | 20.62 | $359.10B | 1.87% | - | 16.39% | 3.76% | 9.66% |
| 8 | GS The Goldman Sachs Group, Inc. SPX | 1,140.00 | 20.83 | $336.31B | 1.69% | - | 14.55% | - | 2.21% |
| 9 | WFC Wells Fargo & Company SPX | 85.29 | 13.18 | $261.00B | 2.11% | - | 12.03% | 4.02% | 15.98% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 65.45M | 76.09M | 90.67M | 98.90M | 116.76M | 122.72M | 133.26M | 143.93M | 155.69M |
| Net Income | 5.00M | 6.55M | 8.71M | 7.01M | 5.53M | 12.09M | 11.43M | 12.34M | 15.18M | 16.01M |
| Diluted EPS | - | 0.27 | 0.36 | 0.29 | 0.20 | 0.36 | 0.34 | 0.36 | 0.45 | 0.48 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 187.60M | 283.40M | 425.66M | 551.59M |
| Net Income | 11.26M | 25.05M | 38.24M | 53.79M |
| Diluted EPS | 0.47 | 1.04 | 1.29 | 1.59 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | 1.03B | 1.65B | 2.37B |
| Total Equity | - | 192.08M | 370.18M | 448.27M |
| Cash & Equivalents | 64.66M | 118.07M | 97.48M | 193.54M |
| Long Term Debt | - | - | 0 | 146.45M |
| Total Liabilities | - | 835.78M | 1.28B | 1.92B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 181.64M | 236.22M | 294.29M | 331.59M |
| Investing Cash Flow | -187.46M | -274.76M | -325.88M | -464.39M |
| Financing Cash Flow | -1.00M | 77.66M | 133.89M | 144.52M |
| Capital Expenditure | -3.97M | -3.82M | -3.11M | -5.57M |
| Free Cash Flow | 177.67M | 232.41M | 291.18M | 326.02M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 6.0% | 8.8% | 9.0% | 9.8% |
| ROE % | - | 13.0% | 10.3% | 12.0% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Gallatin Point Capital LLC | 27.31% | 8.97M | $281.65M |
| 2 | American Family Investments, Inc. | 14.31% | 4.70M | $147.63M |
| 3 | American Century Companies Inc | 6.00% | 1.97M | $61.86M |
| 4 | Victory Capital Management Inc. | 4.69% | 1.54M | $48.42M |
| 5 | Polar Capital Holdings PLC | 4.57% | 1.50M | $47.11M |
| 6 | Blackrock Inc. | 4.30% | 1.41M | $44.36M |
| 7 | Vanguard Capital Management LLC | 2.52% | 828.42K | $26.02M |
| 8 | Two Sigma Investments, LP | 1.58% | 518.72K | $16.29M |
| 9 | Gillson Capital LP | 1.33% | 436.24K | $13.70M |
| 10 | Geode Capital Management, LLC | 1.28% | 421.25K | $13.23M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BOW
FMR LLC's Strategic Acquisition of South Bow Corp Shares - GuruFocus
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOMHdUalFRczdIOXlSWlhHSGdmcFpkTU1DZG1sOFBPX0twU3NQUWg4ZmtucnNuekxjT2Iwb2VrQ2E4aVZYQy1HcDdESzg1NzA2WHMxR0dBU0NSTkwybnZJQ2pYeVN1QVVjbHpXYzZHN3ZCbGFVMmpsWjY5eDRhS1lQSmdNcVdheHlqbUgxbW…
Strength Seen in Bowhead Specialty Holdings Inc. (BOW): Can Its 5.3% Jump Turn into More Strength? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOeE9BTF9zek0wbXNyNmNPTGphSVJGMUpCelV0cExnMjNJalJyZm9EYzNSR25SbHVMNm05NVpIRldsOE51dEZEUlhKYkhwbVhiS3VtNXNyS2dPaGM3RUJyWkJkZkxhT0tGRHRWaVB5NmZMckYtU1puelJadS00WjhRRklaRlVZNXMwNWZEZD…
First Community And 2 Other Stocks Estimated To Be Trading Below Their Intrinsic Value - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQeDNUTy1GWGVnenQwWjI4ZWlxM0tZcFFCbkJ5MmdramVybjZSaF9la1pid2Z6WEhoSG9rN2VvalFleHFkSFpKakN5OEI0UV9QRkU5eVhnUWJrQmI5UnZyZWJyaUU1MVNVQ05SeFFEcnFKWWxCNzVYYWdYTWRRaklPT0hua1NaOGdsRUdCZH…
Why (BOW) Price Action Is Critical for Tactical Trading - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPNldkZkg1OWlXSktYdUhVOGo4cGNsOUw1Vmo2VkJ2N29yaWRfWUNmNXdodzhXSWNwVDByVEMxeDVTdk8zWkFhSklTVjlpTDZVOFlEYl9PdjRTbFZKWTQ1TWVkRVk0WE9yNzhRejhiZW1kc3VpTXE0d0QtUzV5bG1aMGx4UlVnNUlUWjJWaF…
Bowhead Specialty (NYSE:BOW) Given New $38.00 Price Target at Royal Bank Of Canada - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQZzV2eldBM0YwTWVWRUE1RmJCZmluZjZoaGlfY3NNLTFwTzdWaEowbHJYNWxHY0UyUVFHMnN3QVotUjRFdFJkYk9IMGpFNXhsai1yLUFUcmFQUW5QNnZCN3A3blNGYzdXUUFjajF6eHF2dGhMTTVpWnJ1bG9FYk1mdElVZG5GOXplcGpnMW…
Enterprise value to EBITDA forward of Boryszew S.A. – MUN:BOW - TradingView
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQYnRGMWxMcjEtWnI3R2FFQ2NtX05WVnpfQUF2LUJwS2VCR0ZGd1ZJYmRCcDk0WDdMX2ZWMjJHcVhnOHVtRnRFMkF0aUstc1Q4YkhSUDl6NTUxZ0NEX0NqanpFUHVITllKYW54RVRaX19PblB0aWJMeHBzZnNqLUQ2MjNxdXFUY0NwM1J0Z1…
BOW — Frequently Asked Questions
What is the current share price of Bowhead Specialty Holdings Inc. (BOW)?
As of 2026-07-14 21:23 PDT, Bowhead Specialty Holdings Inc. (BOW) trades at $30.84 on NYSE. Its 52-week range is $21.44 to $33.94.
What is the market capitalisation of BOW?
Bowhead Specialty Holdings Inc. (BOW) has a market capitalisation of $1.01B on NYSE.
What is the P/E ratio of BOW?
BOW trades at a trailing price-to-earnings (P/E) ratio of 17.83. The industry average P/E is 13.30. Its price-to-book (P/B) ratio is 1.95.
What is the return on equity (ROE) of BOW?
BOW has a return on equity (ROE) of 13.73%.
Is BOW a good stock to buy?
This page provides a data-driven analysis of Bowhead Specialty Holdings Inc. (BOW), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.